Dr. Reddy’s Laboratories informs about press release

05 Jun 2025 Evaluate

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release ‘Alvotech and Dr. Reddy’s enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab) for global markets.’
The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1254.65 -27.30 (-2.13%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×